Skip to main content

Table 1 Characteristics of eligible population receiving colonoscopy/FOBT, mammography or PSA testing in 2018

From: Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study

  Colonoscopy/FOBTa No Colonoscopy/FOBTa Mammo-graphy No Mammography PSA testingb No PSA testingb
N (%) 22′453 (9.2) 221′875 (90.8) 33′747 (20.4) 131′581 (79.6) 49′521 (31.8) 106′423 (68.2)
Male sex (%) 10′876 (48.4) 107′027 (48.2) 0 (0) 0 (0) 49′521 (100) 106′423 (100)
Age in years (mean, sd) 59.8 (5.94) 59.0 (5.90) 61.1 (7.17) 61.9 (7.43) 64.0 (7.36) 60.5 (7.48)
High deductible (%) 4′869 (21.7) 67′033 (30.2) 5′990 (17.7) 30′831 (23.4) 10′204 (20.6) 38′822 (36.5)
Managed care (%) 13′708 (61.1) 134′626 (60.7) 20′684 (61.3) 78′601 (59.7) 29′346 (59.3) 63′850 (60.0)
Suppl. hospital insurance (%) 5′620 (25.0) 48′174 (21.7) 9′795 (29.0) 33′285 (25.3) 12′909 (26.1) 20′838 (19.6)
Language region
 German (%) 16′659 (74.2) 172′012 (77.5) 19′994 (59.2) 106′389 (80.9) 35′531 (71.7) 85′961 (80.8)
 French (%) 3′629 (16.2) 34′750 (15.7) 9′297 (27.5) 17′196 (13.1) 8′724 (17.6) 14′485 (13.6)
 Italian (%) 2′165 (9.6) 15′113 (6.8) 4′456 (13.2) 7′996 (6.1) 5′266 (10.6) 5′977 (5.6)
 Urban region (%) 17′527 (78.1) 169′001 (76.2) 26′611 (78.9) 101′054 (76.8) 38′503 (77.8) 79′373 (74.6)
 Major related surgery/ disease (%) 269 (1.2) 696 (0.3) 2′022 (6.0) 1′164 (0.9) 2′398 (4.8) 1′011 (0.9)
 Chronic conditions (mean, sd) 1.8 (1.87) 1.4 (1.70) 1.8 (1.87) 1.6 (1.85) 2.0 (1.79) 1.3 (1.66)
 Cantonal program (%) 1′359 (6.1) 12′526 (5.6) 21′654 (64.2) 61′795 (47.0) 0 (0) 0 (0)
  1. a FOBT Fecal occult blood testing
  2. b PSA Prostate-specific antigen